HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SLC10A6
solute carrier family 10 member 6
Chromosome 4 · 4q21.3
NCBI Gene: 345274Ensembl: ENSG00000145283.8HGNC: HGNC:30603UniProt: Q3KNW5
15PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Transporter
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingplasma membranebile acid:sodium symporter activitybile acid and bile salt transportlymphatic system cancergoutaortic stenosishypertriglyceridemia 2
✦AI Summary

SLC10A6 encodes a sodium-dependent organic anion transporter (SOAT) that mediates cellular uptake of sulfoconjugated steroid hormones 1. The protein exhibits seven-transmembrane domain topology and functions as a glycosylated, 46 kDa plasma membrane protein 1. SOAT transports dehydroepiandrosterone sulfate, estrone-3-sulfate, and pregnenolone sulfate in a sodium-dependent manner with competitive kinetics 1. Beyond steroid sulfates, SOAT also transports sulfoconjugated bile acids and organosulfates, including taurolithocholic acid-3-sulfate and sulfoconjugated pyrenes 1. The transporter is highly expressed in testis, with significant expression in placenta and pancreas 1. Biologically, SOAT delivers sulfoconjugated steroid precursors to reproductive organs, where steroid sulfatases convert them to biologically active free steroids 2. A notable role involves transporting the estriol precursor 16α-hydroxydehydroepiandrosterone 3-sulfate at fetal blood vessel endothelium 3. In spermatogenesis, SOAT expression in germ cells suggests involvement in male fertility regulation 4. Rare loss-of-function variants in SLC10A6 impair transport activity or membrane expression, potentially affecting reproductive function 4. Experimentally, SOAT inhibitors demonstrate antiproliferative effects on hormone-dependent breast cancer cells 5, establishing therapeutic potential as a drug target.

Sources cited
1
SOAT cloning, transport substrates (steroid sulfates and sulfoconjugated bile acids), tissue expression, protein topology, and kinetic characterization
PMID: 17491011
2
Steroid sulfates as biologically inactive metabolites activated by steroid sulfatases (referenced but full abstract not provided)
PMID: 23667501
3
SOAT role in transporting estriol precursor 16α-OH-DHEAS at fetal blood vessel endothelium and steroid sulfate activation
PMID: 24717977
4
SLC10A6 rare genetic variants affecting SOAT transport function and membrane expression; expression in spermatogenic cells and role in male fertility
PMID: 28893621
5
SOAT inhibitors demonstrate antiproliferative effects on hormone-dependent breast cancer cells and establish SOAT as a drug target
PMID: 39419503
Disease Associationsⓘ20
lymphatic system cancerOpen Targets
0.31Weak
goutOpen Targets
0.17Weak
aortic stenosisOpen Targets
0.07Suggestive
hypertriglyceridemia 2Open Targets
0.06Suggestive
familial hypercholesterolemiaOpen Targets
0.06Suggestive
Combined hyperlipidemiaOpen Targets
0.05Suggestive
thyroid hormone metabolism, abnormal, 2Open Targets
0.04Suggestive
sitosterolemia 2Open Targets
0.04Suggestive
homozygous familial hypercholesterolemiaOpen Targets
0.04Suggestive
congenital anomaly of cardiovascular systemOpen Targets
0.04Suggestive
pancreatic triacylglycerol lipase deficiencyOpen Targets
0.04Suggestive
hypercholesterolemia, autosomal dominant, 3Open Targets
0.04Suggestive
hyperlipidemia due to hepatic triglyceride lipase deficiencyOpen Targets
0.04Suggestive
breast carcinomaOpen Targets
0.03Suggestive
hypercholesterolemia, autosomal dominant, type BOpen Targets
0.03Suggestive
pancreatic adenocarcinomaOpen Targets
0.03Suggestive
hypothyroidismOpen Targets
0.03Suggestive
placental retentionOpen Targets
0.03Suggestive
alcoholic liver diseaseOpen Targets
0.03Suggestive
breast cancerOpen Targets
0.03Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
SLC10A2Shared pathway100%SLC10A3Shared pathway100%SLC10A4Shared pathway100%SLC10A7Protein interaction74%SLC10A5Shared pathway71%STARD5Shared pathway50%
Tissue Expression6 tissues
Heart
100%
Brain
38%
Lung
33%
Liver
15%
Ovary
12%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
SLC10A6SLC10A2SLC10A3SLC10A4SLC10A7SLC10A5STARD5
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q3KNW5
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.20LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.85 [0.62–1.20]
RankingsWhere SLC10A6 stands among ~20K protein-coding genes
  • #15,688of 20,598
    Most Researched15
  • #12,620of 17,882
    Most Constrained (LOEUF)1.20
Genes detectedSLC10A6
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6).
PMID: 17491011
J Biol Chem · 2007
1.00
2
The SLC10 carrier family: transport functions and molecular structure.
PMID: 23177985
Curr Top Membr · 2012
0.90
3
Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.
PMID: 24196564
Pflugers Arch · 2014
0.80
4
The role of sulfated steroids in reproduction.
PMID: 29501777
J Steroid Biochem Mol Biol · 2018
0.70
5
Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT.
PMID: 39419503
J Med Chem · 2024
0.60